Hims & Hers Health, Inc. reported a strong first quarter in 2021, with revenue increasing by 74% year-over-year to $52.3 million. The company's gross margin improved to 77%, and it ended the quarter with 391,000 subscriptions, up nearly 80% year-over-year. However, the net loss increased to $(51.4) million due to one-time stock-based compensation and transaction bonus expenses related to the merger.
Revenue increased by 74% year-over-year to $52.3 million.
Gross margin improved to 77% compared to 69% in the first quarter of 2020.
The company ended the quarter with 391,000 subscriptions, up nearly 80% year-over-year.
Net loss was $(51.4) million, primarily driven by one-time stock-based compensation and transaction bonus expenses related to the merger.
Hims & Hers provides revenue and Adjusted EBITDA guidance for Q2 2021 and full year 2021.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance